Chan Y. Y. Cheah, MD

Haematologist
Linear Clinical Research and Sir Charles Gairdner Hospital and University of Western Australia, Australia

N/A

Poster(s):

• 2003 - Genomic Evolution and Resistance to Pirtobrutinib in Covalent BTK-Inhibitor Pre-treated Chronic Lymphocytic Leukemia Patients: Results from the Phase I/II BRUIN Study

• 2011 - Long-term Safety with ≥12 Months of Pirtobrutinib in Relapsed/Refractory (R/R) B-Cell Malignancies